Jilin Test BIO-Electron Co., Ltd

Jilin Test BIO-Electron Co., Ltd specializes in rapid colorimetric test kits for multiple urine analytes, designed for clinical use. These devices are intended for point-of-care testing, where healthcare professionals can quickly assess patient results through visual color changes in the test strips or kits. The focus is on in vitro diagnostics (IVDs) that provide immediate diagnostic insights in healthcare settings.

Jilin Test BIO-Electron Co., Ltd is based in the United States. As a manufacturer, the company develops and distributes its devices in compliance with U.S. regulatory requirements, including those applicable to in vitro diagnostics. While the company operates primarily in the U.S., its products may also be distributed internationally depending on market demand and regulatory pathways.

Jilin Test BIO-Electron Co., Ltd’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. The UDI system is used to track and identify medical devices throughout their distribution and use, ensuring traceability and regulatory compliance. Listing in this database is a key requirement for Class I devices in the U.S., helping to standardize identification and monitoring.

Jilin Test BIO-Electron Co., Ltd’s devices fall under Class I classification in the U.S. regulatory framework. Class I devices are generally considered to pose the lowest risk and often involve minimal regulatory oversight beyond good manufacturing practices (GMP) and labeling requirements. The classification is based on factors like the device’s intended use, potential risks, and the body’s exposure to the product, ensuring appropriate regulatory scrutiny for their specific category.